资讯

生物谷12 年
VaxInnate启动H5N1候选疫苗VAX161 I期临床试验志愿者招募
中国工程院院士李兰娟7日在京接受新华社记者专访时表示，关闭活禽市场，实施定点屠宰，是源头防控H7N9最为有效的措施；中国自主研制的H7N9禽 ...
生物谷12 年
VaxInnate启动H5N1候选疫苗VAX161 I期临床试验志愿者招募
中国科学家6月24日在线发表于《柳叶刀》上的研究论文称，H7N9禽流感患者死亡风险远低于人感染H5N1禽流感，但高于季节性流感和甲型H1N1 ...
EurekAlert!16 年
VaxInnate to discuss seasonal and pandemic flu vaccines during BIO 2008 this week
SAN DIEGO, CA, June 16, 2008 -- VaxInnate Corporation announced today that it will discuss its novel proprietary technology for producing seasonal and pandemic influenza vaccines during BIO 2008 ...
Yahoo UK & Ireland12 年
VaxInnate's License Agreement with Emergent BioSolutions Improves U.S. Preparedness for ...
VaxInnate's License Agreement with Emergent BioSolutions Improves U.S. Preparedness for Potential Flu Pandemics CRANBURY, N.J.--(BUSINESS WIRE)-- A license agreement for the manufacture and sale ...
Wall Street Journal10 年
VaxInnate Gets Contract Extension From Barda for Vaccine Technology
VaxInnate Corp., whose technology is designed to enable faster production of vaccines, said it has received an extension to its contract with the Biomedical Advanced Research and Development ...
FierceBiotech16 年
VaxInnate's M2e Universal Influenza Vaccine Candidate Demonstrates Safety and ...
CRANBURY, N.J.-(BUSINESS WIRE)-Aug 21, 2008 - VaxInnate Corporation announced today that its M2e universal influenza vaccine candidate was safe and immunogenic in its first Phase I clinical trial ...
Business Wire18 年
VaxInnate Secures $40 Million Series C Financing
CRANBURY, N.J.--(BUSINESS WIRE)--VaxInnate Corporation announced today that it has secured $40 million in a Series C financing. The company is developing novel, proprietary vaccines for both ...
FierceBiotech16 年
VaxInnate's Universal Flu Vaccine Candidate Shown Safe and Immunogenic in Phase I Clinical ...
WASHINGTON--(BUSINESS WIRE)--A universal flu vaccine candidate that could end the need for annual flu shots and provide protection against seasonal and pandemic flu strains was well tolerated and ...
Business Wire12 年
Two New Executives Join VaxInnate Management Team
CRANBURY, N.J.--(BUSINESS WIRE)--VaxInnate Corporation today announced the expansion of its executive management team with the addition of Christine Mayer as Vice President of Business Development ...
FiercePharma12 年
VaxInnate bird flu shot flies into Phase I
VaxInnate's VAX161, the company's vaccine in development to protect against a bird flu pandemic, has moved into Phase I trials. In 2011, VaxInnate was awarded a 5-year contract worth up to $196 ...
AOL12 年
VaxInnate's License Agreement with Emergent BioSolutions Improves U.S. Preparedness for ...
CRANBURY, N.J.--(BUSINESS WIRE)-- A license agreement for the manufacture and sale of VaxInnate Corporation's recombinant flu vaccine by Emergent BioSolutions is a step toward helping the United ...
NJBIZ18 年
VaxInnate Secures 40 Million in Series C Financing
NJBIZ, New Jersey’s leading business journal, provides 24/7 business news coverage and events honoring top business professionals.